Survival advantage of the hemochromatosis C282Y mutation

被引:0
作者
Weinberg, Eugene D. [1 ]
机构
[1] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA
关键词
D O I
暂无
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
The hemochromatosis C282Y mutation is present in up to 12.5% of people in Populations of northern and central European origin. The prevalence of this mutation suggests that it may confer some type of epidermologic advantage. One hypothesis has proposed that female heterozygotes have enhanced dietary iron absorption during their reproductive years, but evidence in support of this concept is not available. A second hypothesis is based on the observation that macrophages in iron-loaded C282Y homozygotes are very low in iron. These persons would be predicted to have increased resistance to pathogens that require iron for growth in macrophages. Notable examples of such pathogens are S. typhi and M. tuberculosis, the bacteria that cause typhoid fever and tuberculosis. Several cellular models that provide evidence for the low-iron macrophage hypothesis have recently been described.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 50 条
  • [31] Hemochromatosis in a Lithuanian with HFE C282Y homozygosity and C282Y allele frequencies in the Baltic Sea Region
    Barton, JC
    Acton, RT
    Prasthofer, EF
    Rivers, CA
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 67 (04) : 263 - 264
  • [32] Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
    Adams, Paul
    Altes, Albert
    Brissot, Pierre
    Butzeck, Barbara
    Cabantchik, Ioav
    Cancado, Rodolfo
    Distante, Sonia
    Evans, Patricia
    Evans, Robert
    Ganz, Tomas
    Girelli, Domenico
    Hultcrantz, Rolf
    McLaren, Gordon
    Marris, Ben
    Milman, Nils
    Nemeth, Elizabeta
    Nielsen, Peter
    Pineau, Brigitte
    Piperno, Alberto
    Porto, Graca
    Prince, Dianne
    Ryan, John
    Sanchez, Mayka
    Santos, Paulo
    Swinkels, Dorine
    Teixeira, Emerencia
    Toska, Ketil
    Vanclooster, Annick
    White, Desley
    HEPATOLOGY INTERNATIONAL, 2018, 12 (02) : 83 - 86
  • [33] Longevity and C282Y mutation for haemochromatosis -: Survival of C282Y homozygotes does not preclude screening for HFE mutations -: Reply
    Coppin, H
    Roth, MP
    Blanché, H
    BRITISH MEDICAL JOURNAL, 2003, 327 (7421): : 991 - 991
  • [34] A European allele map of the C282Y mutation of hemochromatosis:: Celtic versus Viking origin of the mutation?
    Lucotte, G
    Dieterlen, F
    BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (02) : 262 - 267
  • [35] Homozygous mutation of the C282Y gene
    McCashland, TM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (02) : 350 - 351
  • [36] Labile plasma iron in C282Y/C282Y hemochromatosis: A reality of potential pathophysiological and clinical importance.
    Le Lan, C
    Cohen, T
    Ropert, M
    Glickstein, H
    Pouchard, M
    Le Treut, A
    Deugnier, Y
    Loreal, O
    Breuer, W
    Cabantchik, I
    Brissot, P
    HEPATOLOGY, 2003, 38 (04) : 661A - 661A
  • [37] Clinical penetrance of C282Y homozygous HFE hemochromatosis
    Rossi, Enrico
    Olynyk, John K.
    Jeffrey, Gary P.
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) : 205 - 216
  • [38] A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote
    Wallace, DF
    Dooley, JS
    Walker, AP
    GASTROENTEROLOGY, 1999, 116 (06) : 1409 - 1412
  • [39] No association between factor V Leiden and C282Y mutation in the hereditary hemochromatosis gene
    Le Maréchal, C
    Raguénès, O
    Ferec, C
    BLOOD, 1999, 93 (11) : 4024 - 4025
  • [40] A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis
    Gokcan, Hale
    Oz, Didem Kuru
    Bodakci, Emin
    Tunc, Esra
    Idilman, Ramazan
    HEPATOLOGY FORUM, 2024, 5 (03): : 161 - 164